Objective:To observe the clinical effect of gamma globulin at different doses in the treatment of children with severe HFMD.
Methods:A total of 96 children with HFMD at stage Ⅱ and Ⅲ were treated in Zunyi Maternity and Child Health Care Hospital from June 2013 to June 2015,and they were divided randomly into two groups:the small-dose group and the large-dose group,with 48 cases in each group.The two groups were given conventional and symptomatic treatment,and in addition to that,they were injected intravenously different doses of gamma globulin,with 1 g/kg for the small-dose group and 2 g/kg for the large-dose group.Compare the time for clinical symptoms to disappear,the time of being clinically cured,the hospital stay,the complications and the hospitalization expenses between the two groups.
Results:There was no statistical difference in the time for clinical symptoms to disappear,the time of being clinically cured and the hospital stay(P>0.05).The complication incidence was 16.7%(8/48) in the large-dose group,higher than the small-dose one,which was 2.1%(1/48),and the difference was statistical significance(P<0.05).The expense in the small-dose group was lower.
Conclusion:The effect of gamma globulin at different doses is similar and significant in the treatment of severe HFMD.When the dose is 1 g/kg,the treatment expense is lower and the complication incidence is lower,so it is worthy of being clinically applied.